Trial Profile
Postmenopausal women with early hormone receptor positive breast cancer or no metastasis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 09 Apr 2008 New trial record.